Breakthroughs in bladder cancer detection have taken a significant step forward with the NHS's at-home urine test showing promise in identifying nearly nine out of ten cases.

A recent study published in European Urology Oncology, led

Developed years research evaluation, galeas

Developed after years of research and evaluation, the Galeas urine test scrutinises genetic material shed into urine for more than 450 DNA mutations associated with bladder cancer across 23 genes.

Read More: Baby Tommy's Here, Chelsea's Not: Emotional Family Reunion Captivates Fans

This game-changing technology has the potential to significantly reduce the number of patients requiring urgent cystoscopies – invasive procedures that involve inserting a small camera up the urethra and into the bladder.

With over 300,000 cystoscopies performed annually in the UK, this test could mean tens of thousands of patients are spared these tests if successful, alleviating significant waiting lists in some areas.

"Very promising early performance" has been

Under a licensing agreement, the at-home test has been commercialized, offering hope for patients and families affected

Also Read: Why People Are Saying 'Less Is More' in a World of Endless Digital Work

"Too many people are waiting longer than they should for a bladder cancer diagnosis," said Michelle Mitchell from CRUK. "It's essential that we find ways to tackle this problem."

Bladder cancer is more common in men over 60, with blood in urine being the primary symptom. Early detection and treatment save lives.